Ginkgo Bioworks Holdings (DNA) Cash from Investing Activities (QoQ) (2021 - 2026)
Ginkgo Bioworks Holdings (DNA) Cash from Investing Activities (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ginkgo Bioworks Holdings | 445.24 Mn | 301.37 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -75.68% |
| Dec 31, 2025 | 230.60% |
| Sep 30, 2025 | -13.97% |
| Jun 30, 2025 | 67.84% |
| Mar 31, 2025 | -1,418.41% |
| Dec 31, 2024 | -28.28% |
| Sep 30, 2024 | 62.00% |
| Jun 30, 2024 | -121.64% |
| Mar 31, 2024 | 74.05% |
| Dec 31, 2023 | -1,280.48% |
| Sep 30, 2023 | 69.88% |
| Jun 30, 2023 | 42.19% |
| Mar 31, 2023 | -165.28% |
| Dec 31, 2022 | 163.98% |
| Sep 30, 2022 | -217.03% |
| Jun 30, 2022 | 59.25% |
| Mar 31, 2022 | -951.11% |
| Dec 31, 2021 | 113.86% |
| Sep 30, 2021 | -27.48% |
| Jun 30, 2021 | -3.84% |